Abstract. The effects of the dopamine (DA) agonist bromocriptine on prolactin (Prl) 
bromocriptine on prolactin (Prl) (TRH) and elevated extracellular K+ concentration was completely blocked by bromocriptine, whereas the basal release was only moderately affected. The TRH and K+ evoked Prl release were half maximally inhibited by bromocriptine at 5\p=n-\10and 10\p=n-\50 \g=m\m,respectively.
The normal biphasic membrane response to TRH and the depolarizing effect of elevated K+ concentration were not altered by bromocriptine, whereas the Ca2+\x=req-\ spikes in Na+-free solution were suppressed by the drug. We therefore suggest that bromocriptine blocks the voltage sensitive Ca2+-channels of GH3 cells. In agreement with this notion, bromocriptine also suppressed the basal and TRH induced 45Ca2+ efflux from preloaded cells. We conclude that the inhibitory effect of bromocriptine on the voltage dependent Ca2+\x=req-\ channels is an important mechanism responsible for suppression of Prl release.
The dominant influence of the hypothalamus on the Prl secretion is inhibitory (Meites 1972) , and several studies have suggested dopamine (DA) as the major candidate for the role as Prl inhibiting factor (PIF) (Hill-Samli & MacLeod 1974 ).
The semi-synthetic ergot alkaloid 2-Br-cx-ergocrvptinemesvlate (bromocriptine, ) is a po¬ tent DA agonist (Clark et al. 1978 ). This The cells were exposed to the drug at least 15 min before penetration. Fig. 4 shows the result from one of these experiments, and it is evident that the normal biphasic TRH response persists under these conditions. However, the late depolarization failed to induce spontaneous firing of action po- The low density of DA receptors in the GH3 cells (Cronin et al. 1980) 
